NASDAQ · INDV
Indivior Pharmaceuticals, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for INDV has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $1.07 | $1.07 | $1.07 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · Zacks · RTTNews · NASDAQ.com- Fintel · Oct 29, 12:01 PM EDTIndivior PLC Reports Third Quarter 2026 Financial ResultsIndivior PLC reported its financial results for the third quarter ended September 30, 2026, with total net revenue increasing 13% year-over-year to $356 million compared to $314 million for the third quarter ended September 30, 2025. The company achieved record quarterly total SU
- Zacks · Oct 29, 7:35 AM EDTIndivior Pharmaceuticals Inc. (INDV) Beats Q3 Earnings and Revenue EstimatesIndivior Pharmaceuticals Inc. (INDV) delivered earnings and revenue surprises of +41.94% and +8.97%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Oct 29, 7:15 AM EDTIndivior Plc. Announces Climb In Q3 Income(RTTNews) – Indivior plc. (INDV.L) reported a profit for its third quarter that Increases, from last year
- NASDAQ.com · Oct 12, 4:24 PM EDTAfter Hours Most Active for Oct 12, 2026 : NU, CMCSA, INDV, CTRI, NVDA, SNAP, TRVI, TJX, GOOGL, AMZN, CBZ, NOKThe NASDAQ 100 After Hours Indicator is down -10.15 to 30,654.55. The total After hours volume is currently 121,212,545 shares traded.The following are the most active stocks for the after hours session: Nu Holdings Ltd. (NU) is -0.03 at $15.98, with 7,305,742 shares traded. NU'
- NASDAQ.com · Oct 9, 4:24 PM EDTAfter Hours Most Active for Oct 9, 2026 : FTXR, NVDA, BKD, GRAB, TRVI, URGN, INDV, LUV, WFC, ESI, OSG, BACThe NASDAQ 100 After Hours Indicator is down -5.38 to 30,877.77. The total After hours volume is currently 134,392,844 shares traded.The following are the most active stocks for the after hours session: First Trust Nasdaq Transportation ETF (FTXR) is unchanged at $41.53, with 18
- Zacks · Sep 24, 8:45 AM EDTHere's Why Indivior Pharmaceuticals Inc. (INDV) is a Strong Growth StockThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- RTTNews · Sep 17, 8:03 AM EDTIndivior Pharmaceuticals Declares $8.13 Special Cash Dividend Contingent On Pending Merger; Stock Up(RTTNews) – Indivior Pharmaceuticals, Inc. (INDV) announced that its Board of Directors has declared a special cash dividend of $8.13 per share, with payment contingent upon the closing of its previously announced merger with Supernus Pharmaceuticals, Inc. The dividend applies
- Zacks · Sep 14, 9:30 AM EDT5 Small Drug Stocks Poised to Benefit From a Biotech RecoveryINDV, IRWD, RLMD, LRMR and CRDL could offer significant upside as biotech sentiment improves, backed by catalysts and differentiated pipelines.
- Zacks · Sep 2, 11:30 AM EDTIndivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound?Indivior Pharmaceuticals Inc. (INDV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks · Aug 31, 9:45 AM EDTWhy Indivior Pharmaceuticals Inc. (INDV) is a Top Growth Stock for the Long-TermThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- Zacks · Aug 31, 9:35 AM EDTIndivior Pharmaceuticals Inc. (INDV) Loses 12.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerIndivior Pharmaceuticals Inc. (INDV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- Zacks · Aug 27, 12:45 PM EDT3 Reasons Why Growth Investors Shouldn't Overlook Indivior Pharmaceuticals Inc. (INDV)Indivior Pharmaceuticals Inc. (INDV) possesses solid growth attributes, which could help it handily outperform the market.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Indivior Pharmaceuticals, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.